Musculoskeletal Disorders (MSDs) are inflammatory and/or degenerative ailments affecting all sectors and all categories of workers, and are by far the most common work-related health problem in the European industry. The biggest Europe-wide occupational health survey found 46% of European workers reporting back pain, while 43% had painful shoulder, neck and upper limb muscles. HEGO is an innovative solution based on a proprietary set of Artificial Intelligence algorithms able to recognize the workers’ gender, age, posture and movements in real-time and monitor ergonomics to adapt both workspace and workload according to worker’s personal profile, to inform about potential MSDs risks, and to provide insights for improving the work environments. HEGO contributes to promote health and safety in industrial workplaces (Human-centered manufacturing concept) by providing a low cost and easy solution.
We have been developing HEGO technology since our foundation (2017) and it has now achieved technology readiness level (TRL) 6. The overall goal of the Women TechEU project is to advance the business readiness level of our product to catalyse a equity investment in Emoj and to improve our market traction. To achieve this we established the following specific objectives for the project:
-) Develop a business plan for the quantification of economic and financial indices within the next 5 years.
-) Provide a market analysis
-) Empower our IPR positioning
-) Become a B Corp company, with a B impact assessment score of 80
-) Sign two agreements with potential customers
-) Improve our brand identity and deliver promotional materials.
